Additionally, there are 51 targets containing in both potential targets of DGLHD and liver fibrosis-associated targets, such as PTGS2, NF-κBp65, PPAR-γ, and PIK3CA (Figure 2 and Supplementary Table 6), indicating the possible effects of DGLHD protecting against hepatic fibrosis. The gene discussed is PPARG; the disease is Hepatic fibrosis.